134 related articles for article (PubMed ID: 36972253)
1. Deep learning neural network image analysis of immunohistochemical protein expression reveals a significantly reduced expression of biglycan in breast cancer.
Thiesen AP; Mielczarski B; Savaris RF
PLoS One; 2023; 18(3):e0282176. PubMed ID: 36972253
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer dataset with biomarker Biglycan.
Silva Neto PCD; Kunst R; Barbosa JLV; Leindecker APT; Savaris RF
Data Brief; 2023 Apr; 47():108978. PubMed ID: 36879615
[TBL] [Abstract][Full Text] [Related]
3. Expression and the Prognostic Value of Biglycan in Gastric Cancer.
Hu S; Li P; Wang C; Liu X
Comput Math Methods Med; 2022; 2022():2656480. PubMed ID: 36110576
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value and association with epithelial-mesenchymal transition and molecular subtypes of the proteoglycan biglycan in advanced bladder cancer.
Schulz GB; Grimm T; Sers C; Riemer P; Elmasry M; Kirchner T; Stief CG; Karl A; Horst D
Urol Oncol; 2019 Aug; 37(8):530.e9-530.e18. PubMed ID: 31176613
[TBL] [Abstract][Full Text] [Related]
5. Biglycan as a potential diagnostic and prognostic biomarker in multiple human cancers.
Zhao SF; Yin XJ; Zhao WJ; Liu LC; Wang ZP
Oncol Lett; 2020 Mar; 19(3):1673-1682. PubMed ID: 32194659
[TBL] [Abstract][Full Text] [Related]
6. Expression of Biglycan in First Trimester Chorionic Villous Sampling Placental Samples and Altered Function in Telomerase-Immortalized Microvascular Endothelial Cells.
Chui A; Gunatillake T; Brennecke SP; Ignjatovic V; Monagle PT; Whitelock JM; van Zanten DE; Eijsink J; Wang Y; Deane J; Borg AJ; Stevenson J; Erwich JJ; Said JM; Murthi P
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1168-1179. PubMed ID: 28408374
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer.
Jacobsen F; Kraft J; Schroeder C; Hube-Magg C; Kluth M; Lang DS; Simon R; Sauter G; Izbicki JR; Clauditz TS; Luebke AM; Hinsch A; Wilczak W; Wittmer C; Büscheck F; Höflmayer D; Minner S; Tsourlakis MC; Huland H; Graefen M; Budäus L; Thederan I; Salomon G; Schlomm T; Melling N
Neoplasia; 2017 Sep; 19(9):707-715. PubMed ID: 28830008
[TBL] [Abstract][Full Text] [Related]
8. Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy.
Vaxevanis CK; Bauer M; Subbarayan K; Friedrich M; Massa C; Biehl K; Al-Ali HK; Wickenhauser C; Seliger B
Oncoimmunology; 2023; 12(1):2152998. PubMed ID: 36531688
[TBL] [Abstract][Full Text] [Related]
9. Biglycan, tumor endothelial cell secreting proteoglycan, as possible biomarker for lung cancer.
Morimoto H; Hida Y; Maishi N; Nishihara H; Hatanaka Y; Li C; Matsuno Y; Nakamura T; Hirano S; Hida K
Thorac Cancer; 2021 May; 12(9):1347-1357. PubMed ID: 33709550
[TBL] [Abstract][Full Text] [Related]
10. Weakly-supervised deep learning for ultrasound diagnosis of breast cancer.
Kim J; Kim HJ; Kim C; Lee JH; Kim KW; Park YM; Kim HW; Ki SY; Kim YM; Kim WH
Sci Rep; 2021 Dec; 11(1):24382. PubMed ID: 34934144
[TBL] [Abstract][Full Text] [Related]
11. The small leucine-rich proteoglycan BGN accumulates in CADASIL and binds to NOTCH3.
Zhang X; Lee SJ; Young MF; Wang MM
Transl Stroke Res; 2015 Apr; 6(2):148-55. PubMed ID: 25578324
[TBL] [Abstract][Full Text] [Related]
12. Biglycan promotes hepatic fibrosis through activating heat shock protein 47.
Yu M; He X; Song X; Gao J; Pan J; Zhou T; Wang Q; Zhu W; Ma H; Zeng H; Xu C; Yu C
Liver Int; 2023 Feb; 43(2):500-512. PubMed ID: 36371672
[TBL] [Abstract][Full Text] [Related]
13. High expression of biglycan is associated with poor prognosis in patients with esophageal squamous cell carcinoma.
Zhu YH; Yang F; Zhang SS; Zeng TT; Xie X; Guan XY
Int J Clin Exp Pathol; 2013; 6(11):2497-505. PubMed ID: 24228112
[TBL] [Abstract][Full Text] [Related]
14. AutoIHC-Analyzer: computer-assisted microscopy for automated membrane extraction/scoring in HER2 molecular markers.
Tewary S; Arun I; Ahmed R; Chatterjee S; Mukhopadhyay S
J Microsc; 2021 Jan; 281(1):87-96. PubMed ID: 32803890
[TBL] [Abstract][Full Text] [Related]
15. Biglycan, a Nitric Oxide-Downregulated Proteoglycan, Prevents Nitric Oxide-Induced Neuronal Cell Apoptosis via Targeting Erk1/2 and p38 Signaling Pathways.
Chen S; Guo D; Zhang W; Xie Y; Yang H; Cheng B; Wang L; Yang R; Bi J; Feng Z
J Mol Neurosci; 2018 Sep; 66(1):68-76. PubMed ID: 30088173
[TBL] [Abstract][Full Text] [Related]
16. HER-2/neu-mediated down-regulation of biglycan associated with altered growth properties.
Recktenwald CV; Leisz S; Steven A; Mimura K; Müller A; Wulfänger J; Kiessling R; Seliger B
J Biol Chem; 2012 Jul; 287(29):24320-9. PubMed ID: 22582394
[TBL] [Abstract][Full Text] [Related]
17. Interclass small leucine-rich repeat proteoglycan interactions regulate collagen fibrillogenesis and corneal stromal assembly.
Chen S; Young MF; Chakravarti S; Birk DE
Matrix Biol; 2014 Apr; 35():103-11. PubMed ID: 24447998
[TBL] [Abstract][Full Text] [Related]
18. Biglycan induces the expression of osteogenic factors in human aortic valve interstitial cells via Toll-like receptor-2.
Song R; Zeng Q; Ao L; Yu JA; Cleveland JC; Zhao KS; Fullerton DA; Meng X
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2711-20. PubMed ID: 22982459
[TBL] [Abstract][Full Text] [Related]
19. Prior to Initiation of Chemotherapy, Can We Predict Breast Tumor Response? Deep Learning Convolutional Neural Networks Approach Using a Breast MRI Tumor Dataset.
Ha R; Chin C; Karcich J; Liu MZ; Chang P; Mutasa S; Pascual Van Sant E; Wynn RT; Connolly E; Jambawalikar S
J Digit Imaging; 2019 Oct; 32(5):693-701. PubMed ID: 30361936
[TBL] [Abstract][Full Text] [Related]
20. Digital breast tomosynthesis versus digital mammography: integration of image modalities enhances deep learning-based breast mass classification.
Li X; Qin G; He Q; Sun L; Zeng H; He Z; Chen W; Zhen X; Zhou L
Eur Radiol; 2020 Feb; 30(2):778-788. PubMed ID: 31691121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
